Caring Brands vs Alaunos Therapeutics
CABR and TCRT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CABR and TCRT compare
Caring Brands is the larger company, worth 2.0 times as much as Alaunos Therapeutics ($8.3M against $4.1M).
Alaunos Therapeutics scores higher on the StockData Score (4 against 3 for Caring Brands), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CABR | TCRT |
|---|---|---|
| Size and price | ||
| Market cap | $8.3M | $4.1M |
| Share price | $0.805 | $1.63 |
| Change, 1 year | −82.5% | −45.5% |
| Change, 5 years | – | −99.2% |
| Beta (5Y) | – | −0.42 |
| Employees | – | 1 |
| StockData Score | ||
| Total score | 3 | 4 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 1380× |
| P/B | 1.1× (better) | 6.4× |
| Growth | ||
| Revenue growth (TTM) | – | −50.0% |
| Profitability | ||
| Operating margin | – | −135267% |
| Net margin | – | −133667% |
| Return on equity | −142% (better) | −186% |
| Return on invested capital | −377% (better) | −489% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −25.0× | – |
| Current ratio | 16.32 (better) | 0.77 |
| Altman Z-score | 6.49 (better) | −861.79 |
| Piotroski F-score | – | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 1.5% | 3.6% |
| Held by insiders | 15.6% | 69.8% |
| Short interest, % of float | 0.07% | 24.0% |
Go deeper
- CABR stock overview
- CABR income statement
- CABR valuation and score
- TCRT stock overview
- TCRT income statement
- TCRT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.